Sign In
Buy VRTX
$441.74
+13.40 (+3.13%)
At Close: Jun 04, 2026
3 Cheap Biotech Stocks to Buy Now: May 2024
10:24am, Tuesday, 14'th May 2024
The biotech industry is notably risky, but can produce stocks that see massive gains within a day. How can this happen?
Vertex Pharmaceuticals Is Racing Towards a New Blockbuster: Why the Stock Is a Smart Buy
02:47pm, Sunday, 12'th May 2024
Vertex Pharmaceuticals is inching closer to a new approval in its central therapeutic area. The company's lineup is getting stronger, and its pipeline is progressing smoothly.
2 Unbelievable Growth Stocks You Can Buy and Hold for the Next Decade
12:20pm, Sunday, 12'th May 2024
The healthcare and beauty spaces are two significantly large industries. Vertex Pharmaceuticals is capitalizing on the success of its mainstay products while working aggressively towards a stream of n
Will the Biotech Sector Shift From Lagger to Leader?
07:24am, Friday, 10'th May 2024
The biotech sector and its popular ETF, the iShares Biotechnology ETF NASDAQ: IBB, have lagged the overall market during the year, with its shares slightly red. However, in recent weeks, the sector ha
Vertex (VRTX) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
10:36am, Wednesday, 08'th May 2024
Although the revenue and EPS for Vertex (VRTX) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street e
5 Reasons Vertex Pharmaceuticals Is a Screaming Buy on the Dip
05:43am, Wednesday, 08'th May 2024
Since 2012, Vertex has been the only drugmaker with treatments that address the root cause of cystic fibrosis. Vertex Pharmaceuticals recently received FDA approval for a gene therapy developed in par
Vertex's (VRTX) Q1 Earnings Beat, Trikafta Drives Sales
10:46am, Tuesday, 07'th May 2024
Vertex's (VRTX) first-quarter earnings and revenues surpass estimates. Higher sales of Trikafta/Kaftrio in U.S. and ex-U.S. markets drive the top line.
Vertex Pharmaceuticals, Inc. (VRTX) Q1 2024 Earnings Call Transcript
09:31pm, Monday, 06'th May 2024
Vertex Pharmaceuticals, Inc. (NASDAQ:VRTX ) Q1 2024 Earnings Conference Call May 6, 2024 4:30 PM ET Company Participants Susie Lisa - SVP, IR Reshma Kewalramani - CEO, President & Director Stuart Arbu
Vertex Pharmaceuticals Shines in the First Quarter
06:19pm, Monday, 06'th May 2024
Vertex's strong revenue growth was driven by Trikafta/Kaftrio sales, particularly in international markets. The biotech acquired Alpine Immune Sciences, and advanced several pipeline candidates.
Vertex Pharmaceuticals (VRTX) Q1 Earnings and Revenues Top Estimates
06:11pm, Monday, 06'th May 2024
Vertex Pharmaceuticals (VRTX) came out with quarterly earnings of $4.76 per share, beating the Zacks Consensus Estimate of $4.10 per share. This compares to earnings of $3.05 per share a year ago.
Vertex tops Q1 profit estimates on robust demand for cystic fibrosis treatments
04:11pm, Monday, 06'th May 2024
Vertex Pharmaceuticals beat Wall Street estimates for first-quarter profit on Monday, driven by robust uptake for its cystic fibrosis treatments.
Vertex Reports First Quarter 2024 Financial Results
04:01pm, Monday, 06'th May 2024
BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today reported consolidated financial results for the first quarter ended March 31, 2024, and reiterated full year 2024 fina
3 Biotech Stocks to Double Your Money in the Next 24 Months
02:30pm, Monday, 06'th May 2024
The biotechnology sector is renowned for its potential to deliver groundbreaking medical treatments while offering investors the possibility of significant returns. However, investing in these compani
3 No-Brainer Stocks to Buy in May
06:55am, Sunday, 05'th May 2024
It's always a good time to buy shares of Eli Lilly. Pfizer is undervalued and underrated.
Shhh! 3 Secret Gene Editing Stocks Flying Below Wall Street's Radar
02:18pm, Friday, 03'rd May 2024
Gene editing stocks are among the most intriguing in the biotech scene. The genomics revolution may be as exciting as the ongoing artificial intelligence one.
